The European Innovation Council (EIC) equity fund will no longer be managed internally by the European Commission (EC) after September. Alterdomus Management Co. SA, a Luxembourg-based fund manager, will make the final decisions on which life science companies to invest in. The aim is to optimize how the EU’s main tool for driving innovation and economic growth in Europe operates.
Mediwhale Inc. closed a $9 million series A round that will see the company take its artificial intelligence (AI)-powered retina scans to prevent heart and kidney diseases to the U.S. market.
Using direct current to stimulate a chronic wound can help it to heal up to three times faster, researchers from Chalmers Institute of Technology, Sweden, and the University of Freiburg, Germany, found. Working from a well-known hypothesis that the skin is electrostatic, the researchers engineered a microfluidic biochip on which skin cells were cultured. They then made tiny wounds in two cells. One was allowed to heal naturally while the other was stimulated with electricity.
Elidah Inc. expanded its line of U.S. FDA-cleared, over-the-counter devices to reduce or eliminate urinary incontinence in women with the launch of Elitone Urge for urge incontinence. The device is a muscle stimulator that can be worn under clothes as the user goes about her day and rebuilds muscle tone.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Directsync Surgical, Jogo Health, Kurin, Olympus.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cerus Endovascular, Curasight, Curium Pharma, Insightec, Personalis, Quipt Home Medical, Smith+Nephew, Stryker, Vivasure.
New hires and promotions in the med-tech industry, including: CS Genetics, Conventus Flower Orthopedics, Corvent Medical, Quantum-Si, Tivic Health Systems.
RSS
